| Mackenzie Krebsbach Roberts, CRNP | |
|
2451 University Hospital Dr, Mobile, AL 36617-2300 | |
| (251) 471-7565 | |
| Not Available |
| Full Name | Mackenzie Krebsbach Roberts |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 2451 University Hospital Dr, Mobile, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003351727 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2100X | Nurse Practitioner - Acute Care | 1-138001 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Usa Health Physician Billing Services Llc | 9931436912 | 266 |
News Archive
TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings, today announced that the Company has received purchase orders for multiple devices from the US. The orders are the result of the collaborative relationship between Getinge Infection Control, its sales and service provider, and the Company.
Today's headlines include stories and analysis of how the Ryan budget plan would change Medicare, Medicaid and the shape of the federal government.
Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's APTIMA HPV 16 18/45 Genotype Assay for use on its TIGRIS instrument system.
Prof Cornely heads the Clinical Trials Center and the Translational Research Platform at the CECAD Excellence Cluster at the University of Cologne. In addition to his research activities, as a senior physician at the Clinic I of Internal Medicine of the Cologne University Hospital he is responsible for clinical therapies for mycological infections.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited received final approval on July 20 from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Minocycline Hydrochloride Extended Release Tablets (Minocycline ER), 45 mg, 90 mg and 135 mg, the generic version of Solodyn® ER, a treatment for acne, sold by Medicis Pharmaceuticals Corporation (Medicis). Mylan Pharmaceuticals Inc. commenced immediate shipment of the product after approval.
› Verified 2 days ago
| Entity Name | University Of South Alabama |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992746838 PECOS PAC ID: 3072425149 Enrollment ID: O20040115000773 |
News Archive
TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings, today announced that the Company has received purchase orders for multiple devices from the US. The orders are the result of the collaborative relationship between Getinge Infection Control, its sales and service provider, and the Company.
Today's headlines include stories and analysis of how the Ryan budget plan would change Medicare, Medicaid and the shape of the federal government.
Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's APTIMA HPV 16 18/45 Genotype Assay for use on its TIGRIS instrument system.
Prof Cornely heads the Clinical Trials Center and the Translational Research Platform at the CECAD Excellence Cluster at the University of Cologne. In addition to his research activities, as a senior physician at the Clinic I of Internal Medicine of the Cologne University Hospital he is responsible for clinical therapies for mycological infections.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited received final approval on July 20 from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Minocycline Hydrochloride Extended Release Tablets (Minocycline ER), 45 mg, 90 mg and 135 mg, the generic version of Solodyn® ER, a treatment for acne, sold by Medicis Pharmaceuticals Corporation (Medicis). Mylan Pharmaceuticals Inc. commenced immediate shipment of the product after approval.
› Verified 2 days ago
| Entity Name | Usa Health Physician Billing Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720645468 PECOS PAC ID: 9931436912 Enrollment ID: O20190814000827 |
News Archive
TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings, today announced that the Company has received purchase orders for multiple devices from the US. The orders are the result of the collaborative relationship between Getinge Infection Control, its sales and service provider, and the Company.
Today's headlines include stories and analysis of how the Ryan budget plan would change Medicare, Medicaid and the shape of the federal government.
Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's APTIMA HPV 16 18/45 Genotype Assay for use on its TIGRIS instrument system.
Prof Cornely heads the Clinical Trials Center and the Translational Research Platform at the CECAD Excellence Cluster at the University of Cologne. In addition to his research activities, as a senior physician at the Clinic I of Internal Medicine of the Cologne University Hospital he is responsible for clinical therapies for mycological infections.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited received final approval on July 20 from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Minocycline Hydrochloride Extended Release Tablets (Minocycline ER), 45 mg, 90 mg and 135 mg, the generic version of Solodyn® ER, a treatment for acne, sold by Medicis Pharmaceuticals Corporation (Medicis). Mylan Pharmaceuticals Inc. commenced immediate shipment of the product after approval.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mackenzie Krebsbach Roberts, CRNP Po Box 1355, Orange Beach, AL 36561-1355 Ph: () - | Mackenzie Krebsbach Roberts, CRNP 2451 University Hospital Dr, Mobile, AL 36617-2300 Ph: (251) 471-7565 |
News Archive
TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings, today announced that the Company has received purchase orders for multiple devices from the US. The orders are the result of the collaborative relationship between Getinge Infection Control, its sales and service provider, and the Company.
Today's headlines include stories and analysis of how the Ryan budget plan would change Medicare, Medicaid and the shape of the federal government.
Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's APTIMA HPV 16 18/45 Genotype Assay for use on its TIGRIS instrument system.
Prof Cornely heads the Clinical Trials Center and the Translational Research Platform at the CECAD Excellence Cluster at the University of Cologne. In addition to his research activities, as a senior physician at the Clinic I of Internal Medicine of the Cologne University Hospital he is responsible for clinical therapies for mycological infections.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited received final approval on July 20 from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Minocycline Hydrochloride Extended Release Tablets (Minocycline ER), 45 mg, 90 mg and 135 mg, the generic version of Solodyn® ER, a treatment for acne, sold by Medicis Pharmaceuticals Corporation (Medicis). Mylan Pharmaceuticals Inc. commenced immediate shipment of the product after approval.
› Verified 2 days ago
Mrs. Jennifer Gallagher Williams, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1601 Center St, Ste 1s, Mobile, AL 36604 Phone: 251-410-5437 Fax: 251-434-3852 | |
Mrs. Kathleen R. Carlen-magnone, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6801 Airport Blvd, Mobile, AL 36608 Phone: 251-639-5775 Fax: 251-631-3581 | |
Kayla Clemons, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6144 Airport Blvd, Mobile, AL 36608 Phone: 251-476-5050 Fax: 251-450-2770 | |
Lauren Marie Mcminn, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1855 Spring Hill Ave, Mobile, AL 36607 Phone: 251-471-3544 Fax: 251-476-7456 | |
Katherine Kinsaul, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5 Mobile Infirmary Cir, Mobile, AL 36607 Phone: 251-435-2620 | |
Wesley Kyle Dees, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2451 University Hospital Dr, Mstn 101, Mobile, AL 36617 Phone: 251-445-8282 Fax: 251-445-8281 |